Global Liraglutide Market Analysis and Forecast 2024-2030

Global Liraglutide Market Analysis and Forecast 2024-2030


Summary

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

According to APO Research, The global Liraglutide market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liraglutide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Liraglutide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Liraglutide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Liraglutide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liraglutide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Liraglutide, also provides the sales of main regions and countries. Of the upcoming market potential for Liraglutide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liraglutide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liraglutide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liraglutide sales, projected growth trends, production technology, application and end-user industry.

Liraglutide segment by Company

HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Liraglutide segment by Type

Pills
Liquid
Liraglutide segment by Application

Hospital
Drug Store
Liraglutide segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liraglutide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liraglutide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liraglutide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Liraglutide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Liraglutide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liraglutide sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Liraglutide Market by Type
1.2.1 Global Liraglutide Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Pills
1.2.3 Liquid
1.3 Liraglutide Market by Application
1.3.1 Global Liraglutide Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug Store
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Liraglutide Market Dynamics
2.1 Liraglutide Industry Trends
2.2 Liraglutide Industry Drivers
2.3 Liraglutide Industry Opportunities and Challenges
2.4 Liraglutide Industry Restraints
3 Global Market Growth Prospects
3.1 Global Liraglutide Revenue Estimates and Forecasts (2019-2030)
3.2 Global Liraglutide Revenue by Region
3.2.1 Global Liraglutide Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Liraglutide Revenue by Region (2019-2024)
3.2.3 Global Liraglutide Revenue by Region (2025-2030)
3.2.4 Global Liraglutide Revenue Market Share by Region (2019-2030)
3.3 Global Liraglutide Sales Estimates and Forecasts 2019-2030
3.4 Global Liraglutide Sales by Region
3.4.1 Global Liraglutide Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Liraglutide Sales by Region (2019-2024)
3.4.3 Global Liraglutide Sales by Region (2025-2030)
3.4.4 Global Liraglutide Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Liraglutide Revenue by Manufacturers
4.1.1 Global Liraglutide Revenue by Manufacturers (2019-2024)
4.1.2 Global Liraglutide Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Liraglutide Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Liraglutide Sales by Manufacturers
4.2.1 Global Liraglutide Sales by Manufacturers (2019-2024)
4.2.2 Global Liraglutide Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Liraglutide Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Liraglutide Sales Price by Manufacturers (2019-2024)
4.4 Global Liraglutide Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Liraglutide Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Liraglutide Manufacturers, Product Type & Application
4.7 Global Liraglutide Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Liraglutide Market CR5 and HHI
4.8.2 2023 Liraglutide Tier 1, Tier 2, and Tier 3
5 Liraglutide Market by Type
5.1 Global Liraglutide Revenue by Type
5.1.1 Global Liraglutide Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Liraglutide Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Liraglutide Revenue Market Share by Type (2019-2030)
5.2 Global Liraglutide Sales by Type
5.2.1 Global Liraglutide Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Liraglutide Sales by Type (2019-2030) & (K MT)
5.2.3 Global Liraglutide Sales Market Share by Type (2019-2030)
5.3 Global Liraglutide Price by Type
6 Liraglutide Market by Application
6.1 Global Liraglutide Revenue by Application
6.1.1 Global Liraglutide Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Liraglutide Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Liraglutide Revenue Market Share by Application (2019-2030)
6.2 Global Liraglutide Sales by Application
6.2.1 Global Liraglutide Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Liraglutide Sales by Application (2019-2030) & (K MT)
6.2.3 Global Liraglutide Sales Market Share by Application (2019-2030)
6.3 Global Liraglutide Price by Application
7 Company Profiles
7.1 HEC Pharm
7.1.1 HEC Pharm Comapny Information
7.1.2 HEC Pharm Business Overview
7.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 HEC Pharm Liraglutide Product Portfolio
7.1.5 HEC Pharm Recent Developments
7.2 Bachem
7.2.1 Bachem Comapny Information
7.2.2 Bachem Business Overview
7.2.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Bachem Liraglutide Product Portfolio
7.2.5 Bachem Recent Developments
7.3 Bharat Pharmaceuticals
7.3.1 Bharat Pharmaceuticals Comapny Information
7.3.2 Bharat Pharmaceuticals Business Overview
7.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Bharat Pharmaceuticals Liraglutide Product Portfolio
7.3.5 Bharat Pharmaceuticals Recent Developments
7.4 Kingpep Biotechnology
7.4.1 Kingpep Biotechnology Comapny Information
7.4.2 Kingpep Biotechnology Business Overview
7.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Kingpep Biotechnology Liraglutide Product Portfolio
7.4.5 Kingpep Biotechnology Recent Developments
7.5 Shenzhen JYMed Technology
7.5.1 Shenzhen JYMed Technology Comapny Information
7.5.2 Shenzhen JYMed Technology Business Overview
7.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Shenzhen JYMed Technology Liraglutide Product Portfolio
7.5.5 Shenzhen JYMed Technology Recent Developments
7.6 Wuxi Asiapeptide
7.6.1 Wuxi Asiapeptide Comapny Information
7.6.2 Wuxi Asiapeptide Business Overview
7.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Wuxi Asiapeptide Liraglutide Product Portfolio
7.6.5 Wuxi Asiapeptide Recent Developments
7.7 AmbioPharm
7.7.1 AmbioPharm Comapny Information
7.7.2 AmbioPharm Business Overview
7.7.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 AmbioPharm Liraglutide Product Portfolio
7.7.5 AmbioPharm Recent Developments
8 North America
8.1 North America Liraglutide Market Size by Type
8.1.1 North America Liraglutide Revenue by Type (2019-2030)
8.1.2 North America Liraglutide Sales by Type (2019-2030)
8.1.3 North America Liraglutide Price by Type (2019-2030)
8.2 North America Liraglutide Market Size by Application
8.2.1 North America Liraglutide Revenue by Application (2019-2030)
8.2.2 North America Liraglutide Sales by Application (2019-2030)
8.2.3 North America Liraglutide Price by Application (2019-2030)
8.3 North America Liraglutide Market Size by Country
8.3.1 North America Liraglutide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Liraglutide Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Liraglutide Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Liraglutide Market Size by Type
9.1.1 Europe Liraglutide Revenue by Type (2019-2030)
9.1.2 Europe Liraglutide Sales by Type (2019-2030)
9.1.3 Europe Liraglutide Price by Type (2019-2030)
9.2 Europe Liraglutide Market Size by Application
9.2.1 Europe Liraglutide Revenue by Application (2019-2030)
9.2.2 Europe Liraglutide Sales by Application (2019-2030)
9.2.3 Europe Liraglutide Price by Application (2019-2030)
9.3 Europe Liraglutide Market Size by Country
9.3.1 Europe Liraglutide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Liraglutide Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Liraglutide Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Liraglutide Market Size by Type
10.1.1 China Liraglutide Revenue by Type (2019-2030)
10.1.2 China Liraglutide Sales by Type (2019-2030)
10.1.3 China Liraglutide Price by Type (2019-2030)
10.2 China Liraglutide Market Size by Application
10.2.1 China Liraglutide Revenue by Application (2019-2030)
10.2.2 China Liraglutide Sales by Application (2019-2030)
10.2.3 China Liraglutide Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Liraglutide Market Size by Type
11.1.1 Asia Liraglutide Revenue by Type (2019-2030)
11.1.2 Asia Liraglutide Sales by Type (2019-2030)
11.1.3 Asia Liraglutide Price by Type (2019-2030)
11.2 Asia Liraglutide Market Size by Application
11.2.1 Asia Liraglutide Revenue by Application (2019-2030)
11.2.2 Asia Liraglutide Sales by Application (2019-2030)
11.2.3 Asia Liraglutide Price by Application (2019-2030)
11.3 Asia Liraglutide Market Size by Country
11.3.1 Asia Liraglutide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Liraglutide Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Liraglutide Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Liraglutide Market Size by Type
12.1.1 MEALA Liraglutide Revenue by Type (2019-2030)
12.1.2 MEALA Liraglutide Sales by Type (2019-2030)
12.1.3 MEALA Liraglutide Price by Type (2019-2030)
12.2 MEALA Liraglutide Market Size by Application
12.2.1 MEALA Liraglutide Revenue by Application (2019-2030)
12.2.2 MEALA Liraglutide Sales by Application (2019-2030)
12.2.3 MEALA Liraglutide Price by Application (2019-2030)
12.3 MEALA Liraglutide Market Size by Country
12.3.1 MEALA Liraglutide Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Liraglutide Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Liraglutide Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Liraglutide Value Chain Analysis
13.1.1 Liraglutide Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Liraglutide Production Mode & Process
13.2 Liraglutide Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Liraglutide Distributors
13.2.3 Liraglutide Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings